Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
ENvue Medical, Inc.: Certificate of Correction filed to fix a typographical error in the Floor Price definition in the Certificate of Designation for Series G Preferred Stock, changing it from $1.02 to $1.91 (effective 2025-07-08).
- Change
- charter amendment
- Effective
- 2025-07-08
Exact text from the filing
On July 8, 2025, NanoVibronix, Inc. (the “ Company ”) filed with the Secretary of State of the State of Delaware, a certificate of correction (the “ Certificate of Correction ”) to the Company’s Certificate of Designation of the Preferences, Rights and Limitations of Series G Preferred Stock (the “ Certificate of Designations ”). The Certificate of Correction corrects an inadvertent typographical error in the definition of “Floor Price” in Section 1 of the Certificate of Designation, which should have been stated to be “$1.91” and was instead stated as “$1.02.”
View on SEC.gov